The Download link is Generated: Download https://ec.europa.eu/health/documents/community-register/2017/20170424137382/anx_137382_en.pdf


Esbriet INN-pirfenidone

Send a question via our website www.ema.europa.eu/contact produktu Esbriet do obrotu oraz zalece? w sprawie jego stosowania. Co to jest produkt Esbriet ...



Esbriet INN-pirfenidone

Szczegó?owe informacje o tym produkcie leczniczym s? dost?pne na stronie internetowej Europejskiej. Agencji Leków http://www.ema.europa.eu. Page 17. 17. 1.



Esbriet INN-pirfenidone

28 lut 2011 Detailed information on this medicinal product is available on the website of the European Medicines. Agency http://www.ema.europa.eu. Page 15 ...



Esbriet INN-Pirfenidone

16 gru 2010 Esbriet. International Nonproprietary Name: pirfenidone. Procedure No. ... Authorisation to the European Medicines Agency (EMA) for Esbriet ...



Esbriet INN-pirfenidone

25 cze 2021 Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 ... authorisation for Esbriet (pirfenidone).



Esbriet INN-pirfenidone

14 pa? 2021 Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 ... Active substance(s): pirfenidone. Procedure No.



Esbriet INN-Pirfenidone

22 maj 2014 In April 2012 in response to Esbriet PSUR 1



Esbriet INN-pirfenidone

Esbriet 267 mg hard capsules. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each capsule contains 267 mg pirfenidone. For the full list of excipients 



Esbriet INN-Pirfenidone

Esbriet 267 mg hard capsules. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each capsule contains 267 mg pirfenidone. For the full list of excipients 



Esbriet INN-Pirfenidone